Search Results 81-90 of 17307 for Teratogenic

  1. A Study to Evaluate Fractionated Radiation Therapy Utilizing GRID Therapy for Locally-advanced Bulky Tumors - Mayo Clinic

    Any of the following because this study involves an agent that has known genotoxic, mutagenic and teratogenic effects: Pregnant women;; Nursing women;; Women ...

  2. Chemotherapy Alone or Chemotherapy Plus Radiation Therapy in Treating Patients with Locally Advanced Rectal Cancer Undergoing Surgery - Mayo Clinic

    Any of the following because this study involves an agent that has known genotoxic, mutagenic and teratogenic effects. Pregnant women; Nursing women; Men or ...

  3. Sorafenib Tosylate With or Without Everolimus in Treating Patients With Advanced, Radioactive Iodine Refractory Hurthle Cell Thyroid Cancer - Mayo Clinic

    Not pregnant and not nursing, because this study involves an investigational agent whose genotoxic, mutagenic and teratogenic effects on the developing fetus ...

  4. ShortStop-HER2: 12 Months Vs. 6 Months Of HER2-targeted Medications For People With HER2+ Breast Cancer Who Had A Pathologic Complete Response After Chemotherapy Plus Trastuzumab - Mayo Clinic

    ... teratogenic potential. Therefore, for women of childbearing potential only, a negative serum or urine pregnancy test should be performed prior to receiving ...

  5. Iobenguane I-131 Or Crizotinib And Standard Therapy In Treating Younger Patients With Newly-Diagnosed High-Risk Neuroblastoma Or Ganglioneuroblastoma - Mayo Clinic

    ... teratogenic effects have been noted for several of the study drugs; a pregnancy test is required for female patients of childbearing potential - Lactating ...

  6. A Study to Test the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) with One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors - Mayo Clinic

    Pregnant women may not participate in this study because with cabozantinib, nivolumab, and ipilimumab have potential for teratogenic or abortifacient effects.

  7. Naloxegol in Treating Patients With Stage IIIB-IV Non-small Cell Lung Cancer - Mayo Clinic

    Not pregnant and not nursing, because this study involves an investigational agent whose genotoxic, mutagenic and teratogenic effects on the developing fetus ...

  8. Combination Treatment Therapy Approaches for the Treatment of High-Risk Multiple Myeloma, REACH Trial - Mayo Clinic

    ... teratogenic effects on the developing fetus and newborn are unknown: * Pregnant women * Nursing women * Men or women of childbearing potential who are ...

  9. Testing Olaparib and Temozolomide Versus the Usual Treatment for Uterine Leiomyosarcoma After Chemotherapy Has Stopped Working - Mayo Clinic

    have known genotoxic, mutagenic and teratogenic effects. Therefore, for women of childbearing potential only, a negative pregnancy test done ≤ 7 days prior ...

  10. Study Of GI-102 And PD-1 In Glioblastoma - Mayo Clinic

    Any of the following because this study involves an investigational agent, the genotoxic, mutagenic, and teratogenic effects of which on the developing fetus ...